Company profile · Biotech & medical
應用奈米醫材科技股份有限公司 · 6612
Drafted and translated from cited sources, with links to the passages they are based on for your verification. Care is taken to translate its original meaning from Mandarin as closely as possible.
Icares Medicus focuses on the research, development, manufacturing, and sales of high-end ophthalmic medical devices.[1]
Its main products include intraocular lenses used to treat cataracts, myopia, hyperopia, presbyopia, or astigmatism, as well as their surgical delivery systems and related technical services.[1]
The company is based in Zhubei, Taiwan.[2]
| Latest month | Revenue | Year on year | Month on month |
|---|---|---|---|
| 2026-10 | NT$106m | +15.2% | -4.9% |
2024-11 to 2026-10, monthly revenue.
| Last 20 trading days | Net |
|---|---|
| 2026-10-12 to 2026-11-10 | +NT$1m |
Net buying (green) and selling (red) by foreign investors, NT$ at each day's close. All companies.
| Full English name | ICARES MEDICUS, INC. |
|---|---|
| Chinese name | 應用奈米醫材科技股份有限公司 |
| Stock code | 6612 (TPEx) |
| Industry | Biotech & medical |
| Founded | 14 Jul 2011 |
| Listed | 18 Jul 2018 |
| Paid-in capital | NT$523m |
| Chairman | 樂亦宏 |
| President | 陳秉淳 |
| Headquarters | 4F, No16, Sec.2, Sheng Yi Road Zhubei, Hsinchu 30261 Taiwan, R.O.C. |
| Website | https://www.icaresmedicus.com |
| Official business description | 人工水晶體及其植入系統等相關產品之研發、製造及銷售 · 高階醫療器材之表面處理相關產品之研發、製造及銷售 |
Facts from MOPS company basic information, retrieved 03 Nov 2026. The official business description is the company's own entry and can be out of date.
Generated 2026-11-11 00:39.